Cover Image
市場調查報告書

經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管:開發中產品分析

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 358887
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管:開發中產品分析 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年06月01日 內容資訊: 英文 37 Pages
簡介

本報告提供目前開發中的經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管之開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等系統性資訊。

第1章 目錄

第2章 簡介

  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管概要

第3章 開發中的產品

  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管 - 開發中產品:各開發階段
  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管 - 開發中產品:各地區
  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管 - 開發中產品:各法規途徑
  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管 - 開發中產品:各核准時期 (預定)
  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管 - 開發中產品:進行中的臨床實驗

第4章 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管:開發中的開發中產品 (各企業)

  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管企業 - 開發中產品:各開發階段
  • 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管 - 開發中產品:各開發階段

第5章 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管企業與產品概要

  • Acrostak (Schweiz) AG
  • Caliber Therapeutics
  • Concept Medical Inc
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • Micell Technologies, Inc.
  • Sahajanand Medical Technologies Private Limited
  • SurModics, Inc.
  • The Spectranetics Corporation
  • Vascular Nanotransfer Technologies

第6章 經皮冠狀動脈形成術 (PTCA) 藥物釋放型球囊導管:最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0191EPD

GlobalData's Medical Devices sector report, "Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016" provides an overview of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Overview

3. Products under Development

  • 3.1. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
  • 3.2. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory
  • 3.3. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path
  • 3.4. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date
  • 3.5. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials

4. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products under Development by Companies

  • 4.1. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies - Pipeline Products by Stage of Development
  • 4.2. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development

5. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies and Product Overview

  • 5.1. Acrostak (Schweiz) AG Company Overview
    • 5.1.1. Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Caliber Therapeutics Company Overview
    • 5.2.1. Caliber Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Concept Medical Inc Company Overview
    • 5.3.1. Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview
    • 5.4.1. Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Micell Technologies, Inc. Company Overview
    • 5.5.1. Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Sahajanand Medical Technologies Private Limited Company Overview
    • 5.6.1. Sahajanand Medical Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. SurModics, Inc. Company Overview
    • 5.7.1. SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. The Spectranetics Corporation Company Overview
    • 5.8.1. The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Vascular Nanotransfer Technologies Company Overview
    • 5.9.1. Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

6. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters- Recent Developments

  • 6.1. May 19, 2016: EuroPCR 2016: Pantera Lux Drug-Coated Balloon Proves Non-Inferior to Drug-Eluting Stent
  • 6.2. Jan 05, 2016: QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon
  • 6.3. Oct 15, 2015: ISAR-DESIRE 4 Is First Trial to Examine Role of Lesion Preparation before Drug-Coated Balloon Therapy in Restenosis
  • 6.4. Aug 18, 2015: Elixir Medical Receives 2015 Innovator of the Year Award from EK-UNICO
  • 6.5. Jun 25, 2015: The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix Drug Coated Balloon, showing superior efficacy compared to standard PTA
  • 6.6. Jun 09, 2015: CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
  • Table 2: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory
  • Table 3: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path
  • Table 4: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date
  • Table 5: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials
  • Table 6: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies - Pipeline Products by Stage of Development
  • Table 7: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
  • Table 8: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Genie Catheter - Product Status
  • Table 10: Genie Catheter - Product Description
  • Table 11: Caliber Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Drug Delivery Balloon Catheter - Product Status
  • Table 13: Drug Delivery Balloon Catheter - Product Description
  • Table 14: TADD Device - Product Status
  • Table 15: TADD Device - Product Description
  • Table 16: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Magic Touch - Product Status
  • Table 18: Magic Touch - Product Description
  • Table 19: Concept Medical Inc - Ongoing Clinical Trials Overview
  • Table 20: Magic Touch - Assessment of the Novel MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions
  • Table 21: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: PTCA Drug Eluting Balloon - Product Status
  • Table 23: PTCA Drug Eluting Balloon - Product Description
  • Table 24: Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Drug-Coated Balloon - Product Status
  • Table 26: Drug-Coated Balloon - Product Description
  • Table 27: Sahajanand Medical Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Identity Balloon Catheter - Product Status
  • Table 29: Identity Balloon Catheter - Product Description
  • Table 30: SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: SurVeil Drug Coated Balloon - Coronary - Product Status
  • Table 32: SurVeil Drug Coated Balloon - Coronary - Product Description
  • Table 33: The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: AngioSculptX - Product Status
  • Table 35: AngioSculptX - Product Description
  • Table 36: Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Mitomycin-Based DCB - Coronary - Product Status
  • Table 38: Mitomycin-Based DCB - Coronary - Product Description
  • Table 39: Paclitaxel-Based Drug Coated Balloon - Coronary - Product Status
  • Table 40: Paclitaxel-Based Drug Coated Balloon - Coronary - Product Description
  • Table 41: Glossary

List of Figures

  • Figure 1: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
  • Figure 2: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory
  • Figure 3: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path
  • Figure 4: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date
  • Figure 5: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials
Back to Top